Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

UK bans disposable vapes to tackle alarming rise in youth vaping

UK bans disposable vapes to tackle alarming rise in youth vaping

Official figures revealed that the number of children using vapes has tripled in the past three years.

The UK government has decided to ban disposable vapes to tackle the rise in youth vaping and protect children’s health, Prime Minister Rishi Sunak announced on Sunday (28 January 2024) during a visit to a school.


Official figures revealed that the number of children using vapes has tripled in the past three years, with nine per cent of 11 - to 15-year-olds now affected by this rising trend.

Disposable vapes are believed to be mainly driving the worrisome rise in youth vaping, with the number of 11- to 17-year-old vapers using disposables estimated to have increased by almost ninefold in the last two years.

Sunak said: “As any parent or teacher knows, one of the most worrying trends at the moment is the rise in vaping among children, and so we must act before it becomes endemic.

“The long-term impacts of vaping are unknown and the nicotine within them can be highly addictive, so while vaping can be a useful tool to help smokers quit, marketing vapes to children is not acceptable.”

Health Minister Andrea Leadsom believes that a ban on disposable vapes is crucial for stopping youth vaping in its tracks.

“Nicotine is highly addictive - and so it is completely unacceptable that children are getting their hands on these products, many of which are undeniably designed to appeal to young people.

“Along with tougher enforcement measures, we are making sure vapes are aimed at the people they were designed to help - adults who are quitting smoking,” she said.

New measures to crack down on underage sales

New powers will be introduced to restrict vape flavours, introduce plain packaging, and change how vapes are displayed in shops so they don’t appeal to children, the prime minister added.

Moreover, additional fines would be imposed on shops in England and Wales that sell vapes illegally to children, and that would come along with the maximum £2,500 fine that local authorities can already impose.

To tackle underage tobacco and vape sales, the government will also empower trading standards officers to act ‘on the spot’.

Vaping alternatives - such as nicotine pouches - will also be banned in the UK as children are increasingly turning to these highly addictive substitutes, the Department of Health and Social Care (DHSC) said.

Sunak maintained that these changes, alongside the government’s commitment to stop children who turn 15 this year or younger from ever legally being sold cigarettes will leave a “lasting legacy”.

In October 2023, the UK government launched a consultation on smoking and vaping, which received an overwhelming response, with nearly 70 per cent of parents, teachers, healthcare professionals and the general public supporting the disposable vape ban.

Health impacts of smoking and vaping

Smoking remains the single largest preventable cause of death in England, costing the NHS £17 billion each year, said Victoria Atkins, the Secretary of State for Health and Social Care.

There's one smoking-related hospital admissions in England almost every minute, according to her.

“The health advice is clear: vapes should only ever be used as a tool to quit smoking. But we are committed to doing more to protect our children from illicit underage vaping, and by banning disposable vapes we’re preventing children from becoming hooked for life,” she added.

 

 

More For You

Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

iStock

Locums should stand up for their interests, say 'no' to unfair terms: PDA

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to be vigilant about their interests and negotiate directly with their businesses, avoid working with digital platforms driven by algorithms, and be aware of regressive contract terms.

The not-for-profit organisation issued such an advisory following its survey of 1,300 UK locum pharmacists, which showed that they work in a difficult environment and that most are dissatisfied with their jobs.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less